Is Nuclear Medicine Becoming Next Big Breakthrough in Oncology Treatment? Danielle Meyrick episode artwork

EPISODE · Sep 19, 2025 · 34 MIN

Is Nuclear Medicine Becoming Next Big Breakthrough in Oncology Treatment? Danielle Meyrick

from Leading Beyond The Lab

If you're not paying attention to nuclear medicine, Danielle Meyrick will change that in under five minutes.This week, we sit down with Dr. Danielle Meyrick, Director and Co-Founder at EPIC Theranostics, to explore the meteoric rise of nuclear medicine and radiotheranostics. With over 20 years of experience spanning academia, biotech, and hospital environments, Danielle is uniquely positioned as both a scientific pioneer and commercial strategist. Her career has spanned from launching radiopharmaceutical therapies in hospitals to shaping global strategies for biotech companies. If you're serious about understanding the future of oncology, this is the episode to watch. In this episode we cover:Why nuclear medicine is having a moment - and what makes radiotheranostics the most promising modality in oncology today.From PhD to MD – Danielle’s unconventional path to medicine, and how her dual perspective shaped her leadership style.What it takes to commercialise complex therapies – lessons from inside large pharma, mid-stage biotechs, and early-stage ventures.The clinical data that changed everything – and how early adopters leveraged compassionate use to gain momentum.What’s next for EPIC Theranostics – and why workforce readiness and isotope supply could make or break the sector.If you're in biotech, pharma, or medtech, this episode is a masterclass in strategic thinking and scientific depth. Watch now and get ahead of where oncology is going.Follow ARTOLinkedIn: https://www.linkedin.com/company/artotalentSpotify: Leading Beyond The LabInstagram: Instagram (@arto.talent)TikTok: artotalent on TikTokApple Podcasts: Leading Beyond The LabWebsite: HomeYoutube: ARTO RecruitmentDanielle MeyrickCo-Founder + Director At EPIC Theranostiocs LinkedIn: https://www.linkedin.com/in/arndt-schottelius-md-ph/Lawrence RoseCo-Founder + Talent Solutions Director At ARTOLinkedIn: https://www.linkedin.com/in/lawrencerose/Timestamps:00:00 Career Beginnings06:12 Nuclear Medicine09:26 Characteristics of a Good Drug Developer14:13 Future of Radiotheranostics20:05 Approaching Challenges26:52 Advice29:25 Motivations30:56 Greatest Achievements#LeadingBeyondTheLab #ARTOTalent #Biotechnology  Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Sep 19, 2025

Embed this episode

NOW PLAYING

Is Nuclear Medicine Becoming Next Big Breakthrough in Oncology Treatment? Danielle Meyrick

0:00 34:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Leading Beyond The Lab?

This episode is 34 minutes long.

When was this Leading Beyond The Lab episode published?

This episode was published on September 19, 2025.

Can I download this Leading Beyond The Lab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!